Old Web
English
Sign In
Acemap
>
authorDetail
>
William T. Kendrick
William T. Kendrick
Eli Lilly and Company
Antagonist
Internal medicine
Pharmacology
Endocrinology
AMPA receptor
3
Papers
167
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (3)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
MO571PRACTICE PATTERNS ON THE MANAGEMENT OF SECONDARY HYPERPARATHYROIDISM IN THE UNITED STATES: RESULTS FROM A MODIFIED DELPHI PANEL
2021
Nephrology Dialysis Transplantation
David Henner
Beatrice Drambarean
Teresa M. Gerbeling
Jessica Kendrick
William T. Kendrick
Lisa Koester Wiedemann
Thomas L. Nickolas
Anjay Rastogi
Anis A Rauf
Brenda Dyson
Michael C. Singer
Pooja Desai
Kathleen M. Fox
Sunfa Cheng
William G. Goodman
Show All
Source
Cite
Save
Citations (0)
The novel 5-Hydroxytryptamine(1A) antagonist LY426965: effects on nicotine withdrawal and interactions with fluoxetine.
2000
Journal of Pharmacology and Experimental Therapeutics
Kurt Rasmussen
David O. Calligaro
Janet F. Czachura
Laura J. Dreshfield-Ahmad
David C. Evans
Susan K. Hemrick-Luecke
Mary Jeanne Kallman
William T. Kendrick
J. David Leander
David L. Nelson
Carl D. Overshiner
David B. Wainscott
Mary C. Wolff
David T. Wong
Theresa Branchek
John M. Zgombick
Yao-Chang Xu
Show All
Source
Cite
Save
Citations (58)
A selective AMPA antagonist, LY293558, suppresses morphine withdrawal-induced activation of locus coeruleus neurons and behavioral signs of morphine withdrawal
1996
Neuropsychopharmacology
Kurt Rasmussen
William T. Kendrick
Jeffrey H. Kogan
George K. Aghajanian
Show All
Source
Cite
Save
Citations (109)
1